NPM1P35: A Drug Target / Disease Biomarker (G100129067)
NPM1P35: A Drug Target / Disease Biomarker
NPM1P35 is a protein that is expressed in various tissues throughout the body. It is a key regulator of the cell cycle, and is involved in the development and progression of many diseases. Despite its importance, little is known about NPM1P35 specifically. However, its potential as a drug target or biomarker is being investigated.
NPM1P35 is a protein that is expressed in many different tissues throughout the body, including the brain, heart, liver, and muscle. It is a key regulator of the cell cycle, which is the process by which cells grow, divide, and replicate themselves. NPM1P35 helps to control the length of the cell cycle, and is involved in the development and progression of many diseases.
One of the most promising aspects of NPM1P35 is its potential as a drug target. NPM1P35 has been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its role in these diseases has led to the development of NPM1P35-targeting drugs, which are being tested in clinical trials.
In addition to its potential as a drug target, NPM1P35 is also being investigated as a biomarker. The cell cycle is a critical process that is involved in the development and progression of many diseases, and changes in the cell cycle can be used as a biomarker for disease. NPM1P35 has been shown to be expressed in a variety of diseases, including cancer, and its levels may be a useful indicator of disease severity or response to treatment.
Despite its potential as a drug target and biomarker, little is known about NPM1P35 specifically. The exact role that NPM1P35 plays in the cell cycle and its involvement in disease is still being explored. However, its potential as a drug target and biomarker is being actively investigated, and further studies are likely to shed light on its role in the development and progression of many diseases.
Protein Name: Nucleophosmin 1 Pseudogene 35
The "NPM1P35 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NPM1P35 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
NPM1P42 | NPM1P47 | NPM1P48 | NPM2 | NPM3 | NPNT | NPPA | NPPA-AS1 | NPPB | NPPC | NPR1 | NPR2 | NPR3 | NPRL2 | NPRL3 | NPS | NPSR1 | NPSR1-AS1 | NPTN | NPTN-IT1 | NPTX1 | NPTX2 | NPTXR | NPVF | NPW | NPY | NPY1R | NPY2R | NPY4R | NPY4R2 | NPY5R | NPY6R | NQO1 | NQO2 | NR0B1 | NR0B2 | NR1D1 | NR1D2 | NR1H2 | NR1H3 | NR1H4 | NR1I2 | NR1I3 | NR2C1 | NR2C2 | NR2C2AP | NR2E1 | NR2E3 | NR2F1 | NR2F1-AS1 | NR2F2 | NR2F2-AS1 | NR2F6 | NR3C1 | NR3C2 | NR4A1 | NR4A2 | NR4A3 | NR5A1 | NR5A2 | NR6A1 | NRAD1 | NRADDP | NRAP | NRARP | NRAS | NRAV | NRBF2 | NRBF2P4 | NRBP1 | NRBP2 | NRCAM | NRDC | NRDE2 | NREP | NRF1 | NRG1 | NRG2 | NRG3 | NRG4 | NRGN | NRIP1 | NRIP2 | NRIP3 | NRIP3-DT | NRIR | NRK | NRL | NRM | NRN1 | NRN1L | NRON | NRP1 | NRP2 | NRROS | NRSN1 | NRSN2 | NRSN2-AS1 | NRTN | NRXN1
